1. |
1 Blask DE. Melatonin, sleep disturbance and cancer risk.
Sleep Med Rev , 2009, 13(4): 257-264.
|
2. |
Pacchierotti C, Iapichino S, Bossini L, et al . Melatonin in psychiatric disorders: a review on the melatonin involvement in psychiatry. Front Neuroendocrinol , 2001, 22(1): 18-32.
|
3. |
de Castro-Silva C, de Bruin VM, Cunha GM, et al . Melatonin improves sleep and reduces nitrite in the exhaled breath condensate in cystic fibrosis--a randomized, double-blind placebo-controlled study. J Pineal Res , 2010, 48(1): 65-71.
|
4. |
Sainz RM, Reiter RJ, Tan DX, et al . Critical role of glutathione in melatonin enhancement of tumor necrosis factor and ionizing radiation-induced apoptosis in prostate cancer cells in vitro. J Pineal Res , 2008, 45(3): 258-270.
|
5. |
Korkmaz A, Tamura H, Manchester LC, et al . Combination of melatonin and a peroxisome proliferator-activated receptor-gamma agonist induces apoptosis in a breast cancer cell line. J Pineal Res , 2009, 46(1): 115-116.
|
6. |
Pizarro JG, Yeste-Velasco M, Esparza JL, et al . The antiproliferative activity of melatonin in B65 rat dopaminergic neuroblastoma cells is related to the downregulation of cell cycle-related genes. J Pineal Res , 2008, 45(1): 8-16.
|
7. |
Leon-Blanco MM, Guerrero JM, Reiter RJ, et al . Melatonin inhibits telomerase activity in the MCF-7 tumor cell line both in vivo and in vitro. J Pineal Res , 2003, 35(3): 204-11.
|
8. |
Dauchy RT, Blask DE, Dauchy EM, et al . Antineoplastic effects of melatonin on a rare malignancy of mesenchymal origin: melatonin receptor-mediated inhibition of signal transduction, linoleic acid metabolism and growth in tissue-isolated human leiomyosarcoma xenografts. J Pineal Res , 2009, 47(1): 32-42.
|
9. |
D. Moher, A. Liberati, J. Tetzlaff, et al . Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. Journal of Clinical Epidemiology , 2009, 62(10): 1006-1012.
|
10. |
Jadad AR, Moore RA, Carroll D, et al . Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials , 1996, 17(1): 1-12.
|
11. |
Lissoni P, Barni S, Mandalà M, et al . Decreased toxicity and increased efficacy of cancer chemotherapy using the pineal hormone melatonin in metastatic solid tumour patients with poor clinical status. Eur J Cancer , 1999, 35(12): 1688-1692.
|
12. |
Lissoni P, Tancini G, Barni S, et al . Treatment of cancer chemotherapy-induced toxicity with the pineal hormone melatonin. Support Care Cancer , 1997, 5(2): 126-129.
|
13. |
Lissoni P, Chilelli M, Villa S, et al . Five years survival in metastatic non-small cell lung cancer patients treated with chemotherapy alone or chemotherapy and melatonin: a randomized trial. J Pineal Res , 2003, 35(1): 12-15.
|
14. |
晏建军, 沈锋, 王葵, 等. 褪黑素对中晚期肝癌肝动脉化疗栓塞的协同和保护作用. 第二军医大学学报, 2001, 22(9): 858-861.
|
15. |
Lissoni P, Paolorossi F, Ardizzoia A, et al . A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in a poor clinical state. J Pineal Res , 1997, 23(1): 15-19.
|
16. |
Lissoni P. Biochemotherapy with immunomodulating pineal hormones other than melatonin: 5-methoxytryptamine as a new oncostatic pineal agent. Pathol Biol (Paris) , 2007, 55(3-4): 198-200.
|
17. |
Lissoni P, Meregalli S, Nosetto L, et al . Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone. Oncology , 1996, 53(1): 43-46.
|
18. |
Cerea G, Vaghi M, Ardizzoia A, et al . Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations. Anticancer Res , 2003, 23(2C): 1951-1954.
|
19. |
Cucina A, Proietti S, D'Anselmi F, et al . Evidence for a biphasic apoptotic pathway induced by melatonin in MCF-7 breast cancer cells. J Pineal Res , 2009, 46(2): 172-180.
|
20. |
Joo SS, Yoo YM. Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer. J Pineal Res , 2009, 47(1): 8-14.
|
21. |
Watanabe M, Kobayashi Y, Takahashi N, et al . Expression of melatonin receptor (MT1) and interaction between melatonin and estrogen in endometrial cancer cell line. J Obstet Gynaecol Res , 2008, 34(4): 567-573.
|
22. |
Martín-Renedo J, Mauriz JL, Jorquera F, et al . Melatonin induces cell cycle arrest and apoptosis in hepatocarcinoma HepG2 cell line. J Pineal Res , 2008, 45(4): 532-540.
|
23. |
Lissoni P, Barni S, Ardizzoia A, et al . A randomized study with the pineal hormone melatonin versus supportive care alone in patients with brain metastases due to solid neoplasms. Cancer , 1994, 73(3): 699-701.
|
24. |
蒋旭琴, 韩志君, 梅晓冬. 褪黑素对免疫系统的调节作用及其应用研究进展. 细胞与分子免疫学杂志, 2007, 23(11): 1091-1093.
|
25. |
Mills E, Wu P, Seely D, et al . Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis. J Pineal Res , 2005, 39(4): 360-366.
|